Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia.
D000328:Adult; D000368:Aged; D001996:Bronchopneumonia / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008802:Mezlocillin; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use*; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012853:Sisomicin / Q000008:administration & dosage / Q000627:therapeutic use*
D005839:Gentamicins; D010406:Penicillins; D008802:Mezlocillin; D012853:Sisomicin